Intensity Therapeutics Inc
NASDAQ:INTS
Fundamental Analysis

Revenue & Expenses Breakdown
Intensity Therapeutics Inc
Balance Sheet Decomposition
Intensity Therapeutics Inc
Current Assets | 1.7m |
Cash & Short-Term Investments | 929k |
Other Current Assets | 722k |
Non-Current Assets | 1.4m |
PP&E | 116k |
Other Non-Current Assets | 1.3m |
Free Cash Flow Analysis
Intensity Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Intensity Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-15.2m
USD
|
Operating Income
|
-15.2m
USD
|
Other Expenses
|
224k
USD
|
Net Income
|
-15m
USD
|
INTS Profitability Score
Profitability Due Diligence
Intensity Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Intensity Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
INTS Solvency Score
Solvency Due Diligence
Intensity Therapeutics Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Intensity Therapeutics Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INTS Price Targets Summary
Intensity Therapeutics Inc
Dividends
Current shareholder yield for INTS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?